NO167510C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrerInfo
- Publication number
- NO167510C NO167510C NO842969A NO842969A NO167510C NO 167510 C NO167510 C NO 167510C NO 842969 A NO842969 A NO 842969A NO 842969 A NO842969 A NO 842969A NO 167510 C NO167510 C NO 167510C
- Authority
- NO
- Norway
- Prior art keywords
- phenylkinolincarboxyl
- acids
- preparation
- therapeutic active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
- C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51631983A | 1983-07-22 | 1983-07-22 | |
| US60510484A | 1984-04-30 | 1984-04-30 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO842969L NO842969L (no) | 1985-01-23 |
| NO167510B NO167510B (no) | 1991-08-05 |
| NO167510C true NO167510C (no) | 1991-11-13 |
Family
ID=27058797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO842969A NO167510C (no) | 1983-07-22 | 1984-07-20 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0133244B1 (ru) |
| AU (1) | AU583793B2 (ru) |
| CA (1) | CA1288436C (ru) |
| DE (1) | DE3483704D1 (ru) |
| DK (1) | DK358784A (ru) |
| ES (1) | ES534509A0 (ru) |
| FI (1) | FI86987C (ru) |
| GR (1) | GR82234B (ru) |
| HK (1) | HK142395A (ru) |
| HU (1) | HU194832B (ru) |
| IE (1) | IE57627B1 (ru) |
| IL (1) | IL72471A (ru) |
| NO (1) | NO167510C (ru) |
| NZ (1) | NZ208966A (ru) |
| PT (1) | PT78960B (ru) |
| SU (2) | SU1393314A3 (ru) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4889862A (en) * | 1986-08-28 | 1989-12-26 | E. I. Du Pont De Nemours And Company | Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids |
| WO1989006227A1 (en) * | 1987-12-28 | 1989-07-13 | The Dow Chemical Company | Phenoxyphenoxypropionates, intermediates thereof and methods of preparation |
| US4861783A (en) * | 1988-04-26 | 1989-08-29 | E. I. Du Pont De Nemours And Company | 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases |
| US4968702A (en) * | 1989-01-17 | 1990-11-06 | American Cyanamid Company | Substituted quinolinecarboxylic acids |
| US4918077A (en) * | 1989-01-25 | 1990-04-17 | E. I. Du Pont De Nemours & Co., Inc. | 3-phenyl-5,6-dihydrobenz(c)acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents |
| DE3905339A1 (de) * | 1989-02-22 | 1990-09-06 | Basf Ag | Chinolin-4-carbonsaeurederivate und deren verwendung |
| US5393891A (en) * | 1993-06-08 | 1995-02-28 | The Du Pont Merck Pharmaceutical Company | Immunoassay reagents and methods for detecting brequinar and analogs |
| HUP0004807A3 (en) * | 1997-05-28 | 2001-12-28 | Aventis Pharma Inc | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them |
| WO1999032112A1 (en) * | 1997-12-19 | 1999-07-01 | Eli Lilly And Company | Method for treating diabetes |
| AU2003244080A1 (en) * | 2002-06-26 | 2004-01-19 | Kyowa Hakko Kogyo Co., Ltd. | Phosphodiesterase inhibitor |
| US8232310B2 (en) | 2006-12-29 | 2012-07-31 | Georgetown University | Targeting of EWS-FLI1 as anti-tumor therapy |
| CN104395288B (zh) | 2012-04-12 | 2016-12-14 | 乔治城大学 | 用于治疗尤文肉瘤家族肿瘤的方法和组合物 |
| CA2927148A1 (en) | 2013-10-24 | 2015-04-30 | Georgetown University | Methods and compositions for treating cancer |
| CA2930429A1 (en) | 2013-11-22 | 2015-05-28 | Genzyme Corporation | Novel methods for treating neurodegenerative diseases |
| CN107108580B (zh) | 2014-10-09 | 2020-06-30 | 英克特诺治疗公司 | 吲哚酮化合物及其用途 |
| KR102514814B1 (ko) | 2016-03-31 | 2023-03-27 | 온크터널 테라퓨틱스, 인코포레이티드. | 인돌린 유사체 및 이의 용도 |
| SG11201811661TA (en) | 2016-07-29 | 2019-01-30 | Oncternal Therapeutics Inc | Uses of indolinone compounds |
| CA3165512A1 (en) * | 2019-12-26 | 2021-07-01 | Ohio State Innovation Foundation | Methods and compositions for inhibition of dihydroorotate dehydrogenase |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE502610A (ru) * | 1950-04-18 | |||
| US2888346A (en) * | 1955-08-22 | 1959-05-26 | Gen Aniline & Film Corp | Ultra-violet absorbing compounds |
-
1984
- 1984-07-19 EP EP84108523A patent/EP0133244B1/en not_active Expired - Lifetime
- 1984-07-19 CA CA000459263A patent/CA1288436C/en not_active Expired - Lifetime
- 1984-07-19 AU AU30852/84A patent/AU583793B2/en not_active Ceased
- 1984-07-19 DE DE8484108523T patent/DE3483704D1/de not_active Expired - Lifetime
- 1984-07-20 IE IE1873/84A patent/IE57627B1/en not_active IP Right Cessation
- 1984-07-20 SU SU843776940A patent/SU1393314A3/ru active
- 1984-07-20 IL IL72471A patent/IL72471A/xx not_active IP Right Cessation
- 1984-07-20 ES ES534509A patent/ES534509A0/es active Granted
- 1984-07-20 GR GR75386A patent/GR82234B/el unknown
- 1984-07-20 PT PT78960A patent/PT78960B/pt not_active IP Right Cessation
- 1984-07-20 DK DK358784A patent/DK358784A/da not_active Application Discontinuation
- 1984-07-20 NO NO842969A patent/NO167510C/no unknown
- 1984-07-20 FI FI842928A patent/FI86987C/fi not_active IP Right Cessation
- 1984-07-20 HU HU842824A patent/HU194832B/hu not_active IP Right Cessation
- 1984-07-20 NZ NZ208966A patent/NZ208966A/en unknown
-
1986
- 1986-01-06 SU SU864000869A patent/SU1452480A3/ru active
-
1995
- 1995-09-07 HK HK142395A patent/HK142395A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO842969L (no) | 1985-01-23 |
| NO167510B (no) | 1991-08-05 |
| ES8507498A1 (es) | 1985-09-01 |
| IL72471A0 (en) | 1984-11-30 |
| SU1393314A3 (ru) | 1988-04-30 |
| NZ208966A (en) | 1986-12-05 |
| AU3085284A (en) | 1985-01-24 |
| EP0133244B1 (en) | 1990-12-05 |
| EP0133244A2 (en) | 1985-02-20 |
| FI86987B (fi) | 1992-07-31 |
| DK358784A (da) | 1985-01-23 |
| FI86987C (fi) | 1992-11-10 |
| FI842928A (fi) | 1985-01-23 |
| AU583793B2 (en) | 1989-05-11 |
| SU1452480A3 (ru) | 1989-01-15 |
| GR82234B (ru) | 1984-12-13 |
| DE3483704D1 (de) | 1991-01-17 |
| DK358784D0 (da) | 1984-07-20 |
| PT78960A (en) | 1984-08-01 |
| PT78960B (en) | 1986-10-20 |
| ES534509A0 (es) | 1985-09-01 |
| IE57627B1 (en) | 1993-02-10 |
| HU194832B (en) | 1988-03-28 |
| CA1288436C (en) | 1991-09-03 |
| HK142395A (en) | 1995-09-15 |
| EP0133244A3 (en) | 1985-12-11 |
| IL72471A (en) | 1988-11-15 |
| HUT35248A (en) | 1985-06-28 |
| IE841873L (en) | 1985-01-22 |
| FI842928A0 (fi) | 1984-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO160521C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner. | |
| NO171788C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fosfinsyrederivater | |
| NO841568L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater | |
| NO173238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-beta-(karboksyalkenoylamino)-3-cefem-4-karboksylsyre-forbindelser | |
| NO168174C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolforbindelser | |
| NO843979L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater | |
| NO167510C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer | |
| NO169438C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser | |
| NO168355C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| NO161679C (no) | Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider. | |
| NO841542L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater | |
| NO844243L (no) | Fremgangsmaate for fremstilling av terapeutisk virksomme forbindelser | |
| NO162619C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive l-aminosyre-derivater | |
| NO172489C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater | |
| NO159528C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater. | |
| NO814055L (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater | |
| NO165400C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser. | |
| NO172539C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser | |
| NO831588L (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-4-piperidincarbinoler | |
| NO170582C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser | |
| NO168041C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive retinsyreestere av erytromycin. | |
| NO832830L (no) | Fremgangsmaate for fremstilling av alfa-arylalkansyrer | |
| NO169007C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater | |
| NO833527L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater | |
| NO843377L (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater |